Katy Jeannot
Impact in
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 70
-
- Vibrio bacteria research studies 14
- Infections and bacterial resistance 8
- Co-authors
- Patrick Plésiat (35 shared papers)Arnaud Bolard (5 shared papers)Patrick Plésiat (1 shared paper)Patrick Plésiat (5 shared papers)Cédric Muller (5 shared papers)Patrick Plésiat (3 shared papers)Isabelle Broutin (3 shared papers)Pierre‐Edouard Fournier (3 shared papers)
In The Last Decade
Katy Jeannot
90 papers receiving 3.3k citations
Katy Jeannot's Hit Papers
Peers
Comparison fields: 5 of 103
- Molecular Medicine 2.1k
- Applied Microbiology and Biotechnology 244
- Endocrinology 506
- Microbiology 304
- Pharmacology 562
Countries citing papers authored by Katy Jeannot
This map shows the geographic impact of Katy Jeannot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katy Jeannot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katy Jeannot more than expected).
Fields of papers citing papers by Katy Jeannot
This network shows the impact of papers produced by Katy Jeannot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katy Jeannot. The network helps show where Katy Jeannot may publish in the future.
Co-authors
The 25 scholars most cited alongside Katy Jeannot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Hit paper breakdown → | 2017 | 391 |
| 2 | 2017 | 317 | |
| 3 | 2015 | 221 | |
| 4 | 2010 | 187 | |
| 5 | 2005 | 128 | |
| 6 | 2008 | 112 | |
| 7 | 2013 | 96 | |
| 8 | 2006 | 91 | |
| 9 | 2007 | 84 | |
| 10 | 2014 | 80 | |
| 11 | 2015 | 77 | |
| 12 | 2013 | 72 | |
| 13 | 2023 | 67 | |
| 14 | 2017 | 64 | |
| 15 | 2020 | 57 | |
| 16 | 2016 | 55 | |
| 17 | 2012 | 55 | |
| 18 | 2018 | 52 | |
| 19 | 2014 | 52 | |
| 20 | 2020 | 49 |
About Katy Jeannot
Katy Jeannot is a scholar working on Molecular Medicine, Endocrinology, Pharmacology, Microbiology and Clinical Biochemistry, having authored 99 papers that have together received 3.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (70 papers), Bacterial biofilms and quorum sensing (29 papers), Antibiotics Pharmacokinetics and Efficacy (22 papers), Vibrio bacteria research studies (14 papers), Bacterial Genetics and Biotechnology (11 papers), Bacterial Identification and Susceptibility Testing (10 papers), Antimicrobial Peptides and Activities (9 papers) and Infections and bacterial resistance (8 papers). The work is most often cited by research in Molecular Medicine (2.1k citations), Applied Microbiology and Biotechnology (244 citations), Endocrinology (506 citations), Microbiology (304 citations) and Pharmacology (562 citations). Katy Jeannot has collaborated with scholars based in France, Germany and Spain. Frequent co-authors include Patrick Plésiat, Arnaud Bolard, Patrick Plésiat, Patrick Plésiat, Cédric Muller, Patrick Plésiat, Isabelle Broutin, Pierre‐Edouard Fournier, Ina Attrée and Sophie Tiphaine Loeffert. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Clinical Microbiology and Infection, Frontiers in Microbiology and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.